RGCC Onconomics Extracts Plus tests 80+ genes and 50+ natural compounds to provide safe, personalized, and effective insights for cancer care.
Menu
RGCC Onconomics Extracts Plus tests 80+ genes and 50+ natural compounds to provide safe, personalized, and effective insights for cancer care.
Numerous natural substances are recognized for their potential to target cancer. Nonetheless, the effectiveness of these substances can vary from one patient to another. For instance, while turmeric or high doses of vitamin C may benefit some patients, others may not experience any significant impact on their cancer condition.
The Onconomics Extracts+ eliminates uncertainty by evaluating more than 50 natural substances against your specific cancer cells keeping in mind the genetic information.
CTC Count: Gives a snapshot of your disease and acts as a biomarker to assess the disease prognosis and treatment response
Sensitivity of Natural Substances: The result is a comprehensive and personalized analysis of the natural therapies and supplements. Understanding which combination of highly effective natural substances will aid you and your clinician in crafting treatment protocols tailored to your specific condition.
Epigenetic Analysis: Gene expression information plays a pivotal role in cancer diagnosis by providing insights into the activity levels of genes within cancer cells. This information helps clinicians identify specific patterns or signatures associated with different types of cancer, aiding in accurate diagnosis and personalized treatment decisions.
Onconomics Extracts Plus test creates an individualized profile with insights into the most effective natural treatment options for each patient. This test is used by those who are opting for integrative therapies alongside conventional treatments.
The test applies to all types of cancer and not just limited to the following.
The first step towards personalized cancer care is scheduling an appointment with us.
Upon booking the appointment, you get a consultation with our RGCC experts to assess your cancer status.
We guide you through the process of selecting the most effective tests for your specific cancer.
We deliver precise results that guide treatment decisions and enhance outcomes.
“With RGCC’s Onconomics Extracts Plus test, I can assess the effectiveness of natural substances with precision, incorporating gene expression analysis for personalized treatment planning. This holistic approach enhances treatment outcomes and empowers patients to explore natural therapies tailored to their needs. A game-changer in integrative oncology.”
Our RGCC accredited experts are here to help you with their expertise and guide you in your fight against cancer.
Natural substances and extracts that are tested are divided into Class-I (Cytotoxic agents), Class-II (Immunostimulants/immunomodulators), and Class-III (PK Inhibitors).
Our cutting edge diagnostics and personalised tests makes a meaningful difference in the fight against cancer.
Absolutely, tests can be performed while undergoing treatment to assess the effectiveness of the treatment against cancer.
Your blood sample undergoes processing in cutting-edge laboratories by scientists and technicians to deliver insights into your cancer cells.
Yes, all RGCC tests utilize blood samples. However, certain cancers, like glioblastoma and brain tumors, may require additional samples such as CSF or tissue. Otherwise, a peripheral blood sample alone is enough.
Yes, tests like aCGH can pinpoint the origin of an unknown primary tumor by analyzing genetic abnormalities present in tumor cells.
RGCC Metastat is an effective test for identifying secondary tumors development and its potential location. It helps detect secondary tumors through analyzing Circulating Tumor Cells (CTCs) in the bloodstream. The test provides valuable insights into disease progression and metastasis.
Tests personalize treatment regimens by providing crucial information on drugs and therapies tailored to effectively target cancer cells.
Circulating Tumor Cells (CTCs) are cancer cells that have detached from the primary tumor and circulate in the bloodstream. Cancer Stem Cells (CSCs) are a subpopulation of CTCs and both serve as biomarkers for cancer.
Tests like ChemoSNiP and CAMBISeq provide information on the body’s response to the drugs and sensitivity to immunotherapy.
Are you considering integrative or alternative cancer therapies alongside conventional treatments? Onconomics Extracts Plus integrates natural therapies and provides insights into the effectiveness of natural substances. Empower yourself with comprehensive information to make informed decisions about your cancer treatment journey.
Offering personalized tests from RGCC, our mission is to improve treatment outcomes, enhance survival rates, and elevate overall quality of life for those affected by cancer.
© 2025 Neeli Genetics. All Rights Reserved.